A new application about 89891-65-6

One of the oldest and most widely used commercial enzyme inhibitors is aspirin, Safety of 7-Bromo-2-chloroquinoxaline, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 89891-65-6

Safety of 7-Bromo-2-chloroquinoxaline, New research progress on 89891-65-6 in 2021. Redox catalysis has been broadly utilized in electrochemical synthesis due to its kinetic advantages over direct electrolysis. 89891-65-6, Name is 7-Bromo-2-chloroquinoxaline, molecular formula is C8H4BrClN2. In a Patent，once mentioned of 89891-65-6

The disclosure relates to substituted fused heteroaromatic compounds and the use thereof. Specifically, the disclosure provides compounds of the following Formula I: or a pharmaceutically acceptable salt or prodrug thereof, wherein A1-A4, B1-B3, D1-D4 and R1-R3 are defined herein. Compounds having Formula I are kinalse inhibitors. Therefore, compounds of the disclosure may be used to treat clinical conditions caused by DDR functional defects, such as cancer.

One of the oldest and most widely used commercial enzyme inhibitors is aspirin, Safety of 7-Bromo-2-chloroquinoxaline, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 89891-65-6

Reference：
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1959 | ChemSpider